Pancreatic Cancer Research

ResearcherThe University of SydneyActive in the last 2 years

Venessa T. Chin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4630-4451; OpenAlex author ID A5035691346. Sources: OpenAlex.

Their work

Papers
18 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
46
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: 2 papers · 2015: 3 papers · 2016: 1 paper · 2017: 2 papers · 2018: 3 papers · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 18

  1. Chemotherapy and radiotherapy for advanced pancreatic cancer. Last author DOI 10.1002/14651858.cd011044.pub3↗
  2. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2020.09.043↗
  3. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer. Co-author DOI 10.1016/j.celrep.2020.107625↗
  4. Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000003143↗
  5. Chemotherapy and radiotherapy for advanced pancreatic cancer. Co-author DOI 10.1002/14651858.cd011044.pub2↗
  6. Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future. First author DOI 10.1111/imj.13810↗
  7. Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2017-315144↗
  8. Hypermutation In Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2016.09.060↗
  9. Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. First author DOI 10.1126/scitranslmed.aai8504↗
  10. Genomic analyses identify molecular subtypes of pancreatic cancer. Co-author DOI 10.1038/nature16965↗
  11. Second-line treatment in inoperable pancreatic adenocarcinoma: A systematic review and synthesis of all clinical trials. First author DOI 10.1016/j.critrevonc.2015.07.007↗
  12. Whole genomes redefine the mutational landscape of pancreatic cancer. Co-author DOI 10.1038/nature14169↗
  13. Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial. Co-author DOI 10.1158/1078-0432.ccr-15-0426↗
  14. Clinical and pathologic features of familial pancreatic cancer. Co-author DOI 10.1002/cncr.28863↗
  15. Adjuvant chemotherapy in elderly patients with pancreatic cancer. Co-author DOI 10.1038/bjc.2013.722↗
  16. Clinical and molecular characterization of HER2 amplified-pancreatic cancer. Co-author DOI 10.1186/gm482↗
  17. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Co-author DOI 10.1038/nature11547↗
  18. The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Co-author DOI 10.1093/annonc/mdr561↗

Closest collaborators

The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Adnan M. Nagrial · 11 shared papers, 2012–2024 · strength 0.76
  2. Lorraine A. Chantrill · 10 shared papers, 2012–2024 · strength 0.71
  3. Desmond Yip · 4 shared papers, 2015–2024 · strength 0.49
  4. Andrew Victor Biankin · 9 shared papers, 2012–2020 · strength 0.42
  5. Marina Pajic · 8 shared papers, 2012–2020 · strength 0.33
  6. Jaswinder Singh Samra · 7 shared papers, 2012–2020 · strength 0.27
  7. Amber L. Johns · 7 shared papers, 2012–2020 · strength 0.27
  8. Anthony James Gill · 7 shared papers, 2012–2020 · strength 0.27
  9. David Kuang-Fu Chang · 7 shared papers, 2012–2020 · strength 0.27
  10. Lucy Haggstrom · 1 shared paper, 2024 · strength 0.24
  11. Jeremy L. Humphris · 6 shared papers, 2012–2020 · strength 0.22
  12. Angela S. Y. Chou · 5 shared papers, 2013–2020 · strength 0.22
  13. Mark J. Cowley · 4 shared papers, 2013–2020 · strength 0.18
  14. James G. Kench · 4 shared papers, 2012–2020 · strength 0.16
  15. Sean Michael Grimmond · 4 shared papers, 2013–2018 · strength 0.14
  16. Christopher James Scarlett · 3 shared papers, 2012–2020 · strength 0.13
  17. Emily K. Colvin · 3 shared papers, 2012–2020 · strength 0.13
  18. Adrian M. J. Pokorny · 1 shared paper, 2018 · strength 0.11
  19. Neil Donald Merrett · 2 shared papers, 2012–2020 · strength 0.10
  20. Stephan B. Dreyer · 1 shared paper, 2020 · strength 0.07
  21. Peter J. Bailey · 1 shared paper, 2020 · strength 0.07
  22. Nam Quoc Nguyen · 1 shared paper, 2020 · strength 0.07
  23. Thomas Knösel · 1 shared paper, 2020 · strength 0.07
  24. Nigel Balfour Jamieson · 1 shared paper, 2020 · strength 0.07
  25. Colin J. McKay · 1 shared paper, 2020 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.